These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8530646)

  • 1. Effect of opioid blockade on insulin metabolism in polycystic ovarian disease.
    Fulghesu AM; Ciampelli M; Fortini A; Cucinelli F; Guido M; Caruso A; Lanzone A; Mancuso S
    Hum Reprod; 1995 Sep; 10(9):2253-7. PubMed ID: 8530646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.
    Fulghesu AM; Ciampelli M; Guido M; Murgia F; Caruso A; Mancuso S; Lanzone A
    Metabolism; 1998 Feb; 47(2):158-62. PubMed ID: 9472963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome.
    Lanzone A; Fulghesu AM; Guido M; Ciampelli M; Caruso A; Mancuso S
    Hum Reprod; 1994 Dec; 9(12):2242-6. PubMed ID: 7714138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome.
    Guido M; Pavone V; Ciampelli M; Murgia F; Fulghesu AM; Apa R; Caruso A; Mancuso S; Lanzone A
    J Clin Endocrinol Metab; 1998 May; 83(5):1742-5. PubMed ID: 9589685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study.
    Cucinelli F; Soranna L; Perri C; Barini A; Cento RM; Mancuso S; Lanzone A
    Fertil Steril; 2004 Apr; 81(4):1047-54. PubMed ID: 15066462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion.
    Lanzone A; Fulghesu AM; Cucinelli F; Ciampelli M; Caruso A; Mancuso S
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3501-6. PubMed ID: 8530590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease.
    Lanzone A; Fulghesu AM; Fortini A; Cutillo G; Cucinelli F; Di Simone N; Caruso A; Mancuso S
    Hum Reprod; 1991 Sep; 6(8):1043-9. PubMed ID: 1666896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone effects on insulin sensitivity and insulin secretion in hyperandrogenic women.
    Sir-Petermann T; López G; Castillo T; Calvillán M; Rabenbauer B; Wildt L
    Exp Clin Endocrinol Diabetes; 1998; 106(5):389-94. PubMed ID: 9831304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease.
    Fulghesu AM; Lanzone A; Cucinelli F; Caruso A; Mancuso S
    Obstet Gynecol; 1993 Aug; 82(2):191-7. PubMed ID: 8336863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine and metabolic effects of insulin sensitizers in the treatment of patients with polycystic ovary syndrome and hyperinsulinaemia.
    Ciotta L; De Leo V ; Farina M; Pafumi C; La Marca A ; Cianci A
    Gynecol Obstet Invest; 2001; 51(1):44-50. PubMed ID: 11150875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
    Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
    Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, insulin and C-peptide secretion in obese and non obese women with polycystic ovarian disease.
    Mahabeer S; Naidoo C; Joubert SM
    Diabetes Res; 1990 Jun; 14(2):79-82. PubMed ID: 2134217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus.
    Ciampelli M; Fulghesu AM; Guido M; Murgia F; Muzj G; Belosi C; Fortini A; Cento R; Lanzone A
    Horm Res; 1998; 49(6):263-8. PubMed ID: 9623517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.
    Villa P; Fulghesu AM; De Marinis L; Valle D; Mancini A; Pavone V; Caruso A; Lanzone A
    Metabolism; 1997 May; 46(5):538-43. PubMed ID: 9160821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease.
    Anttila L; Koskinen P; Jaatinen TA; Erkkola R; Irjala K; Ruutiainen K
    Hum Reprod; 1993 Aug; 8(8):1179-83. PubMed ID: 8408513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism.
    Villa P; Valle D; Mancini A; De Marinis L; Pavone V; Fulghesu AM; Mancuso S; Lanzone A
    Fertil Steril; 1999 Jan; 71(1):115-21. PubMed ID: 9935127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of opioid antagonists in the treatment of women with glucoregulation abnormalities.
    Guido M; Romualdi D; Lanzone A
    Curr Pharm Des; 2006; 12(8):1001-12. PubMed ID: 16533167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.
    Ciotta L; De Leo V; Galvani F; La Marca A; Cianci A
    Hum Reprod; 1999 Dec; 14(12):2951-8. PubMed ID: 10601077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinaemia.
    Lanzone A; Villa P; Fulghesu AM; Pavone V; Caruso A; Mancuso S
    Hum Reprod; 1995 Jul; 10(7):1653-7. PubMed ID: 8582956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.